Charles River Laboratories (CRL)
$163.5 1.4%
to add to portfolio
AI Score
-
Alternative
2 -
Fundamental
4 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Charles River Laboratories, AI stock picks, stock alerts and much more.
CRL AI Stock Analysis
AI stock analysis for CRL is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Charles River Laboratories (CRL) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
CRL Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Charles River Laboratories (CRL), currently trading at $163.5, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CRL
-
Charles River Laboratories International, Inc.
-
Symbol
CRL
-
Market
NYSE
-
Industry
Medical - Diagnostics & Research
-
Market Cap
8.4B
Similar Stocks
 |
Thermo Fisher Scientific TMO |
$559.7 0.4% |
4 |
 |
Danaher DHR |
$238.4 1.5% |
6 |
 |
Agilent Technologies A |
$147.4 1.8% |
6 |
 |
IQVIA IQV |
$197.4 0.2% |
4 |
 |
LabCorp LH |
$238.6 0.1% |
5 |
News
CRL Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
CRL Financials
CRL Key Metrics
-
Total Revenue
$1B
-
Net Income
$69.7M
-
Earnings per Share
$1.34
-
Free cash flow
$213.1M
-
EBITDA
$117.4M
-
EBITDA Ratio
0.11627
-
Total Assets
$8B
CRL 2-year Revenue & Income
CRL 2-year Free Cash Flow
CRL Technicals
CRL SMA
CRL RSI
FAQ
What's the current price of Charles River Laboratories (CRL) Stock?
The price of an Charles River Laboratories (CRL) share is $163.5.
What's the market cap of Charles River Laboratories?
The current market cap of Charles River Laboratories is 8.4B.
Should I buy or sell CRL?
Charles River Laboratories exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Charles River Laboratories a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Charles River Laboratories stock. There are several bearish signals and market challenges that could negatively impact Charles River Laboratories' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Charles River Laboratories (CRL) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Charles River Laboratories stock right now, as the outlook appears bearish.
What are some stocks similar to Charles River Laboratories (CRL) that investors often compare it to?
Charles River Laboratories (CRL) is often compared to similar stocks such as Thermo Fisher Scientific, Danaher, Agilent Technologies, IQVIA and LabCorp.
What is the forecast for Charles River Laboratories' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Charles River Laboratories' stock price to be around $150.3 in 2026. Starting from the current price of $163.5, this represents a 8.1% change in price, indicating a bearish outlook for the stock.
How to buy Charles River Laboratories (CRL) Stock?
Charles River Laboratories stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Charles River Laboratories shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.